Decoy Therapeutics Director Hanish Arnold Receives 3,000-Share Award

What Happened

• Hanish Arnold C, a director of Decoy Therapeutics Inc. (DCOY), received a grant of 3,000 restricted shares on August 31, 2026. The shares were awarded at $0.00 per share (transaction type: Award/Grant).

Key Details

• Transaction date: 2026-08-31; Form filed: 2026-09-02 (accession 0001233253-26-000006).
• Transaction type/code: A (award/grant).
• Shares granted: 3,000; acquisition price reported: $0.00 (no cash paid).
• Vesting: 100% vests on August 30, 2027 (per footnote F1).
• Post-transaction beneficial ownership: filing notes shares were adjusted for the reverse stock split effective March 6, 2026 (per footnote F2). The Form 4’s specific post-transaction share total is reflected in the filing.
• No indication in this filing of a 10b5-1 plan, tax-withholding surrender, sale, or immediate disposition.

Context

• This was a restricted stock award (compensation), not an open-market purchase or sale. Such grants are common for executive/director compensation and do not, by themselves, indicate a buy or sell signal.
• The shares vest in one year; until vested they may be subject to forfeiture and transfer restrictions.